Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations

被引:39
作者
Sachana, Magdalini [1 ]
Shafer, Timothy J. [2 ]
Terron, Andrea [3 ]
机构
[1] Org Econ Cooperat & Dev, Environm Hlth & Safety Div, 2 Rue Andre Pascal, F-75775 Paris 16, France
[2] US EPA, Rapid Assay Dev Branch, Biomol & Computat Toxicol Div, Ctr Computat Toxicol & Exposure MD B105 03, Durham, NC 27711 USA
[3] European Food Safety Author, PREV Unit, I-43126 Parma, Italy
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 02期
关键词
developmental neurotoxicity; in vitro battery; integrated approaches to testing and assessment; adverse outcome pathways;
D O I
10.3390/biology10020086
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary It is recognized that the current developmental neurotoxicity (DNT) testing paradigm is not fit-for -purpose for the assessment of a large number of chemicals. In the last two decades there have been scientific advances made for evaluating chemical interactions with the developing nervous system that rely on alternative to animal methods. The Organisation for Economic Co-Operation and Development (OECD) provides a forum to develop internationally harmonised guidance to test and assess chemicals for DNT that is primarily based on cellular models. Given the complexity of the developing nervous system and the availability of a number of non-animal methods to address DNT, integration of data from multiple studies is necessary and an OECD framework for organising existing scientific knowledge can be applied as the canvas of this integration. Herein, we provide a brief overview of the OECD DNT project and summarize various achievements of relevance to the project. The review also presents an opportunity to describe considerations for uptake of the DNT non animal methods in a regulatory context. Characterization of potential chemical-induced developmental neurotoxicity (DNT) hazard is considered for risk assessment purposes by many regulatory sectors. However, due to test complexity, difficulty in interpreting results and need of substantial resources, the use of the in vivo DNT test guidelines has been limited and animal data on DNT are scarce. To address challenging endpoints such as DNT, the Organisation for Economic Co-Operation and Development (OECD) chemical safety program has been working lately toward the development of integrated approaches for testing and assessment (IATA) that rely on a combination of multiple layers of data (e.g., in vitro, in silico and non-mammalian in vivo models) that are supported by mechanistic knowledge organized according to the adverse outcome pathway (AOP) framework. In 2017, the OECD convened a dedicated OECD expert group to develop a guidance document on the application and interpretation of data derived from a DNT testing battery that relies on key neurodevelopmental processes and is complemented by zebrafish assays. This review will provide a brief overview of the OECD DNT project and summarize various achievements of relevance to the project. The review also presents an opportunity to describe considerations for uptake of the DNT in an in vitro battery in a regulatory context.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 46 条
  • [1] ADVERSE OUTCOME PATHWAYS: A CONCEPTUAL FRAMEWORK TO SUPPORT ECOTOXICOLOGY RESEARCH AND RISK ASSESSMENT
    Ankley, Gerald T.
    Bennett, Richard S.
    Erickson, Russell J.
    Hoff, Dale J.
    Hornung, Michael W.
    Johnson, Rodney D.
    Mount, David R.
    Nichols, John W.
    Russom, Christine L.
    Schmieder, Patricia K.
    Serrrano, Jose A.
    Tietge, Joseph E.
    Villeneuve, Daniel L.
    [J]. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2010, 29 (03) : 730 - 741
  • [2] [Anonymous], 2007, OECD Guidelines for the Testing of Chemicals. Test No. 225: Sediment-Water Lumbriculus Toxicity Test Using Spiked Sediment. OECD Guidel
  • [3] Reference Compounds for Alternative Test Methods to Indicate Developmental Neurotoxicity (DNT) Potential of Chemicals: Example Lists and Criteria for their Selection and Use
    Aschner, Michael
    Ceccatelli, Sandra
    Daneshian, Mardas
    Fritsche, Ellen
    Hasiwa, Nina
    Hartung, Thomas
    Hogberg, Helena T.
    Leist, Marcel
    Li, Abby
    Mundy, William R.
    Padilla, Stephanie
    Piersma, Aldert H.
    Bal-Price, Anna
    Seiler, Andrea
    Westerink, Remco H.
    Zimmer, Bastian
    Lein, Pamela J.
    [J]. ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2017, 34 (01) : 49 - 74
  • [4] Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods
    Bal-Price, Anna
    Pistollato, Francesca
    Sachana, Magdalini
    Bopp, Stephanie K.
    Munn, Sharon
    Worth, Andrew
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 354 : 7 - 18
  • [5] Recommendation on Test Readiness Criteria for New Approach Methods in Toxicology: Exemplified for Developmental Neurotoxicity
    Bal-Price, Anna
    Hogberg, Helena T.
    Crofton, Kevin M.
    Daneshian, Mardas
    FitzGerald, Rex E.
    Fritsche, Ellen
    Heinonen, Tuula
    Bennekou, Susanne Hougaard
    Klima, Stefanie
    Piersma, Aldert H.
    Sachana, Magdalini
    Shafer, Timothy J.
    Terron, Andrea
    Monnet-Tschudi, Florianne
    Viviani, Barbara
    Waldmann, Tanja
    Westerink, Remco H. S.
    Wilks, Martin F.
    Witters, Hilda
    Zurich, Marie-Gabrielle
    Leist, Marcel
    [J]. ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2018, 35 (03) : 306 - 352
  • [6] International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes
    Bal-Price, Anna
    Crofton, Kevin M.
    Leist, Marcel
    Allen, Sandra
    Arand, Michael
    Buetler, Timo
    Delrue, Nathalie
    FitzGerald, Rex E.
    Hartung, Thomas
    Heinonen, Tuula
    Hogberg, Helena
    Bennekou, Susanne Hougaard
    Lichtensteiger, Walter
    Oggier, Daniela
    Paparella, Martin
    Axelstad, Marta
    Piersma, Aldert
    Rached, Eva
    Schilter, BenoIt
    Schmuck, Gabriele
    Stoppini, Luc
    Tongiorgi, Enrico
    Tiramani, Manuela
    Monnet-Tschudi, Florianne
    Wilks, Martin F.
    Ylikomi, Timo
    Fritsche, Ellen
    [J]. ARCHIVES OF TOXICOLOGY, 2015, 89 (02) : 269 - 287
  • [7] Advancing the Science of Developmental Neurotoxicity (DNT): Testing for Better Safety Evaluation
    Bal-Price, Anna K.
    Coecke, Sandra
    Costa, Lucio
    Crofton, Kevin M.
    Fritsche, Ellen
    Goldberg, Alan
    Grandjean, Philippe
    Lein, Pamela J.
    Li, Abby
    Lucchini, Roberto
    Mundy, William R.
    Padilla, Stephanie
    Persico, Antonio M.
    Seiler, Andrea E. M.
    Kreysa, Joachim
    [J]. ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2012, 29 (02) : 202 - 215
  • [8] Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events
    Baumann, Jenny
    Gassmann, Kathrin
    Masjosthusmann, Stefan
    DeBoer, Denise
    Bendt, Farina
    Giersiefer, Susanne
    Fritsche, Ellen
    [J]. ARCHIVES OF TOXICOLOGY, 2016, 90 (06) : 1415 - 1427
  • [9] Baumann Jenny, 2014, Curr Protoc Toxicol, V59, DOI 10.1002/0471140856.tx1221s59
  • [10] Editor's Highlight: Evaluation of a Microelectrode Array-Based Assay for Neural Network Ontogeny Using Training Set Chemicals
    Brown, Jasmine P.
    Hall, Diana
    Frank, Christopher L.
    Wallace, Kathleen
    Mundy, William R.
    Shafer, Timothy J.
    [J]. TOXICOLOGICAL SCIENCES, 2016, 154 (01) : 126 - 139